𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Thymidine kinase as a predictor of response to chemotherapy in advanced breast cancer

✍ Scribed by Hui-Jian Zhang; B. J. Kennedy; David T. Kiang

Publisher
Springer US
Year
1984
Tongue
English
Weight
474 KB
Volume
4
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Growth fraction as a predictor of respon
Growth fraction as a predictor of response to chemotherapy in node-negative breast cancer
✍ Mohammed A. Aleskandarany; Andrew R. Green; Emad A. Rakha; Rabab A. Mohammed; So πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 218 KB

## Abstract Accurate predictive markers of chemotherapeutic response in early breast cancer are still lacking. The role of tumour growth fraction as a predictor of response to chemotherapy was assessed in early breast cancer. In this study, immunohistochemical expression of MIB1 was studied in a we

Estrogen receptors and responsiveness of
Estrogen receptors and responsiveness of advanced breast cancer to chemotherapy
✍ Bohumil A. Samal; Samuel C. Brooks; Glen Cummings; Luis Franco; Ervin A. Hire; S πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 278 KB πŸ‘ 2 views

We reviewed 89 patients with disseminated breast cancer who had at least one valid estrogen receptor (ER) assay and who underwent one or several trials of chemotherapy. The responses were assessed by two independent extramural reviewers. Of the 89 patients, 81 were evaluable; 28 of 36 (77.8%) ER-pos

Hormonal receptors in locally advanced b
Hormonal receptors in locally advanced breast cancer: Change with response to neoadjuvant chemotherapy?
✍ Don M. Morris; Jackie Edwards; Frank Gelder πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 225 KB πŸ‘ 1 views

## Abstract Twenty‐one cancers in 20 patients with locally advanced breast cancer were studied. Incisional biopsy was performed without using electrocautery. Tissue was obtained for histology and estrogen (ER) and progesterone (PR) receptors. Patients received chemotherapy after biopsy. All respond

Osteoblastic metastatic disease as a the
Osteoblastic metastatic disease as a therapeutic response to adjuvant chemotherapy in breast cancer
✍ Angela L. Demartini; Aman U. Buzdar; George R. Blumenschein πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 262 KB

Included in this study were 43 breast cancer patients treated with adjuvant chemotherapy who presented metastasis only in bone. Forty-two percent had metastasis during chemotherapy, and 58% had metastasis after the completion of chemotherapy. In 66% of the patients, the lesions were osteolytic. Twen